Saving the Lives of People with Blood Cancer
by
Umbilical cord blood (UCB) has huge potential, not only as a successful alternative source of hematopoietic blood cells for transplant/clinical application, but in research and development too. However, too often UCB is overlooked and seen as just an alternative, leaving it an under-utilised resource. UCB in transplantation The advantages of UCB as a source of…
by
In this blog, our Science Communications Manager, Jonathan Kay, looks at a recent study that highlights the potential benefits of selecting a cord blood transplant over a matched related donor for some patients with blood cancer. Introduction When someone needs a stem cell transplant to treat their blood cancer or blood disorder, they can rely on organisations like…
by
An Interview with Diana Hernandez, Anthony Nolan Research Institute’s Head of the Immunotherapy Group Tell us a bit about yourself and your background: My name is Diana Hernandez, and I have recently been appointed Head of the Immunotherapy Group at the Anthony Nolan Research Institute. Prior to my appointment here, I was Principal Scientist…
by
Sarah Dyce, 34, from South London is stepping up her marathon training as she prepares to run to raise money for Anthony Nolan.
by
In 2013, Nilush’s acute myeloid leukaemia returned – and he was told he’d need a stem cell transplant to have any chance of life. After several adult donors dropped out at the last minute, he was told he’d need a cord blood transplant.
by
From 2013 to 2015, Nicki worked for Anthony Nolan as a Logistics Administrator at our Cell Therapy Centre in Nottingham.
In this blog, she reflects upon her very personal reasons for working with us – and the story of her son Archie, who had a stem cell transplant himself.
